Riset dan Pengabdian Masyarakat
Do Research Sosial Service and Innovation
Publikasi Scopus 2024 per tanggal 30 Juni 2024 (499 artikel)
Publikasi Scopus 2024 per tanggal 30 Juni 2024 (499 artikel)
Margiana, Ria (56685900600); Hammid, Ali Thaeer (57192928734); Ahmad, Irfan (58654182200); Alsaikhan, Fahad (40460917700); Turki Jalil, Abduladheem (57219215491); Tursunbaev, Farkhod (57765030100); Umar, Fadilah (57219267501); Romero Parra, Rosario Mireya (24822273400); Fakri Mustafa, Yasser (57203725947)
Current Progress in Aptasensor for Ultra-Low Level Monitoring of Parkinson’s Disease Biomarkers
2024
Critical Reviews in Analytical Chemistry
54
3
617
632
15
3
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132907481&doi=10.1080%2f10408347.2022.2091920&partnerID=40&md5=7b3b84fedb0f6f436d61ca0191620dcd
Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Master’s Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Soetomo General Academic Hospital, Surabaya, Indonesia; Computer Engineering Techniques Department, Faculty of Information Technology, Imam Ja’afar Al-Sadiq University, Baghdad, Iraq; Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia; College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia; Medical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, Iraq; Independent Researcher, “Medcloud” Educational Centre, Tashkent, Uzbekistan; Research Scholar, Department of Science and Innovation, Akfa University, Tashkent, Uzbekistan; Department of Sports Science, Faculty of Sports, Sebelas Maret University, Surakarta, Indonesia; Universidad Continental, Lima, Peru; Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq
In today’s world, Parkinson’s disease (PD) has been introduced as a long-term degenerative disorder of the central nervous system which mainly affects approximately more than ten million people worldwide. The vast majority of diagnostic methods for PD have operated based on conventional sensing platforms, while the traditional laboratory tests are not efficient for diagnosis of PD in the early stage due to symptoms of this common neurodegenerative syndrome starting slowly. The advent of the aptasensor has revolutionized the early-stage diagnosis of PD by measuring related biomarkers due to the myriad advantages of originating from aptamers which can be able to sensitive and selective capture various types of related biomarkers. The progress of numerous sensing platforms and methodologies in terms of biosensors based on aptamer application for PD diagnosis has revealed promising results. In this review, we present the latest developments in myriad types of aptasensors for the determination of related PD biomarkers. Working strategies, advantages and limitations of these sensing approaches are also mentioned, followed by prospects and challenges. © 2022 Taylor & Francis Group, LLC.
Aptamers, Nucleotide; Biomarkers; Biosensing Techniques; Humans; Parkinson Disease; Biotechnology; Diagnosis; Neurodegenerative diseases; aptamer; biological marker; Advanced materials; Aptamers; Aptasensors; Biomedical analysis; Disease biomarker; Electrochemical aptasensor; Optical aptasensor; Optical-; Parkinson’s disease; Sensing platforms; biomarker; biotechnology; monitoring; nervous system disorder; symptom; chemistry; devices; genetic procedures; human; Parkinson disease; procedures; Biomarkers
King Khalid University, KKU, (RGP.02-87-43); King Khalid University, KKU
The authors are grateful to Scientific Research Deanship at King Khalid University, Abha, Saudi Arabia for their financial support through the Large Research Group Project under grant number (RGP.02-87-43).
Taylor and Francis Ltd.
10408347
35754381
Review
Q1
755
6457